MUDr. Michala Pelikanova s.r.o.

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes4 trials
• Chronic kidney disease1 trial
• Diabetic eye disease1 trial
• Obesity1 trial
• Type 1 diabetes1 trial

Phase

• Phase 34 trials

Status

• Completed4 trials

Lead sponsor

• Eli Lilly and Company2 trials
• Novo Nordisk A/S2 trials

Closed trials

• Completed

  A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

  NCT06065540· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

  NCT05803421· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

  NCT04255433· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

  NCT03811561· Phase 3· Novo Nordisk A/S· Source